Fmoc-L-propargylglycine

CAS: 198561-07-8

Ref. 3D-FF40126

Product Information

• Name: Fmoc-L-propargylglycine
• Synonyms: (2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-ynoic acid, (2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)pent-4-ynoic acid, (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-pentynoic acid, (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-ynoic acid, (S)-2-(Fmoc-Amino)-4-Pentynoic Acid, 4-Pentynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-, 4-Pentynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (S)-, Fmoc-(S)-2-Propargylglycine, Fmoc-<span class="text-smallcaps">L</span>-propargylglycine, Fmoc-Pra-Oh, N-Alpha-(9-Fluorenylmethoxycarbonyl)-(S)-2-Amino-4-Pentynoic Acid, N-Alpha-(9-Fluorenylmethoxycarbonyl)-Propargylglycine, N-Alpha-(9-Fluorenylmethyloxycarbonyl)-L-Propargylglycine, Rarechem Bk Pt 0257
• CAS: 198561-07-8

Description

Fmoc-L-propargylglycine is a cyclic peptide that is synthesized by chemical ligation. It has antiviral, anti-tumor, and anti-inflammatory activities. Fmoc-L-propargylglycine inhibits the growth of cancer cells in vitro. The mechanism of action is not fully understood, but it may involve the inhibition of cellular proliferation and the induction of apoptosis. This compound also inhibits epidermal growth factor (EGF) induced cell proliferation in caco-2 cells.

• Brand: Biosynth

Chemical properties

• Molecular weight: 335.35 g/mol
• Formula: C₂₀H₁₇NO₄
• Purity: Min. 98 Area-%
• Color/Form: White Powder
• InChI: InChI=1S/CH4/h1H4
• InChI key: InChIKey=VNWKTOKETHGBQD-UHFFFAOYSA-N
• SMILES: C#CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O